NanoViricides
NNVC
#10368
Rank
C$45.22 M
Marketcap
C$1.97
Share price
3.36%
Change (1 day)
2.75%
Change (1 year)

NanoViricides (NNVC) - Total assets

Total assets on the balance sheet as of September 2025 : C$11.87 Million

According to NanoViricides's latest financial reports the company's total assets are C$11.87 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

NanoViricides - Total assets on balance sheet (from 2006 to 2025)

Total assets by year

Year Total assets Change
2025-06-30C$12 M-31.52%
2024-06-30C$17.53 M-21.62%
2023-06-30C$22.36 M-26.05%
2022-06-30C$30.24 M-19.35%
2021-06-30C$37.5 M15.53%
2020-06-30C$32.46 M84.39%
2019-06-30C$17.6 M-27.81%
2018-06-30C$24.38 M-30.48%
2017-06-30C$35.07 M-26.1%
2016-06-30C$47.46 M-13.9%
2015-06-30C$55.13 M17.8%
2014-06-30C$46.8 M171.33%
2013-06-30C$17.24 M8.39%
2012-06-30C$15.91 M53.48%
2011-06-30C$10.36 M8.91%
2010-06-30C$9.52 M176.07%
2009-06-30C$3.44 M130.57%
2008-06-30C$1.49 M4.5%
2007-06-30C$1.43 M-52.78%
2006-06-30C$3.03 M
2005-06-30N/A

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
C$79.96 B 673,317.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$182.85 B 1,539,732.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$122.87 B 1,034,663.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$118.30 B 996,171.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
C$1.48 B 12,382.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$0.66 B 5,464.77%๐Ÿ‡บ๐Ÿ‡ธ USA